Research paperStudies on the N-[(trans-4-Isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166) receptor in HIT T-15 cells: Displacement of [3H]glibenclamide
References (22)
- et al.
Possibility of ideal blood glucose control by a new oral hypoglycemic agent, (A-4166), and its stimulatory effect on insulin secretion in animals
Diabetes Res Clin Pract
(1991) - et al.
The sulfonylurea receptor
Biochim Biophys Acta
(1992) - et al.
Characterization of the sulfonylurea receptor on beta cell membranes
J Biol Chem
(1988) - et al.
The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells
J Biol Chem
(1987) - et al.
Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets
Biochem Pharmacol
(1989) - et al.
Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel
Eur J Pharmacol
(1991) - et al.
New hypoglycemic agents,
- et al.
N-Acylphenylalanines and related compounds. A new class of oral hypoglycemic agents
J Med Chem
(1988) - et al.
and related compounds. A new class of oral hypoglycemic agents. 2
J Med Chem
(1989) - et al.
Effects of (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas
Pharmacology
(1994)
Effects of d-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic α- and β-cells: Comparative study with glibenclamide
Pharmacology
(1995)
Cited by (23)
Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity
2004, Journal of EthnopharmacologyInteraction of nateglinide with K<inf>ATP</inf> channel in β-cells underlies its unique insulinotropic action
2002, European Journal of PharmacologyComparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs
2002, Metabolism: Clinical and ExperimentalGlucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound
1999, European Journal of PharmacologyChapter 21. Recent Advances in the Development of Agents for the Treatment of Type 2 Diabetes
1998, Annual Reports in Medicinal ChemistryDevelopment and validation of an HPLC method for determination of nateglinide in drug substances
2015, Marmara Pharmaceutical Journal
Copyright © 1996 Published by Elsevier Inc.